3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
10
Neoplasms
5
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Solid Tumors
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solid Tumor
1
Skin Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Noonan Syndrome
1
Neoplasms, Unknown Primary
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Microsatellite Unstable Colorectal Cancer
1
Lung Neoplasms
1
Lung Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
Paclitaxel
4
pembrolizumab
2
pazopanib
2
efatutazone
2
Sorafenib
2
Radiotherapy, Intensity-Modulated
2
trametinib
1
tislelizumab
1
surufatinib
1
spartalizumab
1
sapanisertib
1
lenvatinib
1
fosbretabulin
1
dabrafenib
1
crolibulin
1
combretastatin
1
cabozantinib
1
atezolizumab
1
abemaciclib
1
Taxes
1
Imatinib Mesylate
1
Gefitinib
1
Doxorubicin
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
CUDC-907
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thyroid Carcinoma, Anaplastic
×
cobimetinib
×
Clear all
No trials found.